Jan Boren
Surgery · 2002–2021
A researcher in the Science corpus: 12 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Surgery — 165 citations into it
- Endocrinology, Diabetes and Metabolism — 127 citations into it
- Cancer Research — 34 citations into it
Whom Jan Boren trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Jan Boren's perspective
Ordered by how strongly the researchers Jan Boren trusts endorse each paper. Same corpus, a different order for every researcher.
- Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. (Arteriosclerosis, Thrombosis and Vascular Biology)
- History of Discovery: Inflammation in Atherosclerosis (Arteriosclerosis, Thrombosis and Vascular Biology)
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology (Statistics in Medicine)
- Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (Nature Genetics)
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer (Nature Immunology)
- Atherosclerosis: current pathogenesis and therapeutic options (Nature Medicine)
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. (Circulation Research)
- Safety of anacetrapib in patients with or at high risk for coronary heart disease. (New England Journal of Medicine)
Their papers
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021) — 742 citations
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020) — 1,302 citations
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel (2017) — 3,303 citations
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent (2016) — 617 citations
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med (2016) — 805 citations
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment (2015) — 768 citations
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (2014) — 765 citations
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease (2013) — 2,141 citations
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (2011) — 1,241 citations
- Lipoprotein(a) as a cardiovascular risk factor: current status (2010) — 1,754 citations
- ATVB In Focus Metabolic Syndrome and Atherosclerosis (2008) — 833 citations
- Subendothelial retention of atherogenic lipoproteins in early atherosclerosis (2002) — 1,080 citations